Newmont MD Rodgers sells $164k in NEM stock

Mark C. Rodgers, MD, Africa-Asia Pacific at NEWMONT Corp (NYSE:NEM), sold 1,361 shares of common stock on March 3, 2026, at a price of $120.78, for a total value of $164,381. The sale comes as Newmont shares have surged 176% over the past year, trading at $119.37 with a market capitalization of $129.67 billion.

Following the transaction, Rodgers directly owns 25,756 shares of NEWMONT Corp. The sale was executed under a Rule 10b5-1 trading plan established on November 24, 2025. According to analysis, Newmont appears undervalued at current levels. The platform reveals 16 additional ProTips for NEM, including its 56-year dividend payment streak and perfect Piotroski Score of 9.

In other recent news, Newmont Corp has seen several notable developments. JPMorgan has initiated coverage on Newmont with an overweight rating, projecting a 5% production compound annual growth rate and forecasting an EBITDA margin of around 67% by fiscal 2029. Bernstein has upgraded Newmont’s stock rating to Outperform from Market Perform, reflecting a bullish view on gold and the stock’s sensitivity to gold price changes. Meanwhile, BMO Capital has lowered its price target for Newmont to $140 from $145, citing challenges in the company’s fourth-quarter outlook, including elevated costs and a 7% decline in production year-over-year. Additionally, Newmont’s contained gold in reserves and resources has fallen by approximately 12%. These developments come amid fluctuations in gold prices, influenced by U.S. labor data and geopolitical tensions.